Bentley Cheatham

AlphaVax (United States) — United States

Biochemistry, Genetics and Molecular Biology · Life Sciences

25h-index5.2kcitations49works0.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Metabolism, Diabetes, and Cancer(17), Pancreatic function and diabetes(14), Cancer, Lipids, and Metabolism(11), Protein Kinase Regulation and GTPase Signaling(10), Cancer, Hypoxia, and Metabolism(6)

Publications49 total

FRI605 Inhibition Of Intestinal SGLT1 With Mizagliflozin For The Treatment Of Post-bariatric Hypoglycemia
Journal of the Endocrine Society·2023· 3 citedOpen Access
Data from Obesity Contributes to Ovarian Cancer Metastatic Success through Increased Lipogenesis, Enhanced Vascularity, and Decreased Infiltration of M1 Macrophages
2023Open Access
Supplemental Figure S1 from Obesity Contributes to Ovarian Cancer Metastatic Success through Increased Lipogenesis, Enhanced Vascularity, and Decreased Infiltration of M1 Macrophages
2023Open Access
Supplemental Figure S3 from Obesity Contributes to Ovarian Cancer Metastatic Success through Increased Lipogenesis, Enhanced Vascularity, and Decreased Infiltration of M1 Macrophages
2023Open Access
Supplemental Figure S2 from Obesity Contributes to Ovarian Cancer Metastatic Success through Increased Lipogenesis, Enhanced Vascularity, and Decreased Infiltration of M1 Macrophages
2023Open Access
Supplemental Figure Legends from Obesity Contributes to Ovarian Cancer Metastatic Success through Increased Lipogenesis, Enhanced Vascularity, and Decreased Infiltration of M1 Macrophages
2023Open Access
Supplemental Figure S4 from Obesity Contributes to Ovarian Cancer Metastatic Success through Increased Lipogenesis, Enhanced Vascularity, and Decreased Infiltration of M1 Macrophages
2023Open Access
Supplemental Figure S3 from Obesity Contributes to Ovarian Cancer Metastatic Success through Increased Lipogenesis, Enhanced Vascularity, and Decreased Infiltration of M1 Macrophages
2023Open Access
Supplemental Figure Legends from Obesity Contributes to Ovarian Cancer Metastatic Success through Increased Lipogenesis, Enhanced Vascularity, and Decreased Infiltration of M1 Macrophages
2023Open Access
Supplemental Figure S4 from Obesity Contributes to Ovarian Cancer Metastatic Success through Increased Lipogenesis, Enhanced Vascularity, and Decreased Infiltration of M1 Macrophages
2023Open Access
Supplemental Figure S2 from Obesity Contributes to Ovarian Cancer Metastatic Success through Increased Lipogenesis, Enhanced Vascularity, and Decreased Infiltration of M1 Macrophages
2023Open Access
Supplemental Figure S1 from Obesity Contributes to Ovarian Cancer Metastatic Success through Increased Lipogenesis, Enhanced Vascularity, and Decreased Infiltration of M1 Macrophages
2023Open Access
Data from Obesity Contributes to Ovarian Cancer Metastatic Success through Increased Lipogenesis, Enhanced Vascularity, and Decreased Infiltration of M1 Macrophages
2023Open Access
Assessment of safety and tolerability of remogliflozin etabonate (GSK189075) when administered with total daily dose of 2000 mg of metformin
BMC Pharmacology and Toxicology·2021· 4 citedOpen Access
Obesity Contributes to Ovarian Cancer Metastatic Success through Increased Lipogenesis, Enhanced Vascularity, and Decreased Infiltration of M1 Macrophages
Cancer Research·2015· 93 citedOpen Access
Pharmacokinetics and Pharmacodynamics of the SGLT2 Inhibitor Remogliflozin Etabonate in Subjects with Mild and Moderate Renal Impairment
Drug Metabolism and Disposition·2015· 13 cited
Remogliflozin Etabonate Improves Fatty Liver Disease in Diet-Induced Obese Male Mice
Journal of Clinical and Experimental Hepatology·2015· 82 citedOpen Access
O047 : Remogliflozin etabonate reduces insulin resistance and liver function enzymes: Role for treatment of nash
Journal of Hepatology·2015· 12 cited
Metabolomic signatures in lipid‐loaded HepaRGs reveal pathways involved in steatotic progression
Obesity·2013· 31 citedOpen Access
Isolation and Characterization of Human Adipose-Derived Stem Cells for Use in Tissue Engineering
Methods in molecular biology·2013· 25 cited
page 1 of 3Next →

Frequent Co-authors

Yueying Liu(13), Matthew N. Metzinger(13), Kyle A. Lewellen(13), Stephanie N. Cripps(13), Kyle D. Carey(13), Elizabeth I. Harper(13), Zonggao Shi(13), Laura Tarwater(13), Annie Grisoli(13), Ania Slusarz(13), Elizabeth A. Loughran(13), Jeff Johnson(13), Yuliya Klymenko(13), Lana Bruney(13), Norman J. Dovic̀hi(13), W. Matthew Leevy(13), M. Sharon Stack(13), Eric Lee(12), Jing Yang(12), Kaitlyn Conley(12)